Literature DB >> 34426479

Objective evaluation of nutritional status using the prognostic nutritional index during and after chemoradiotherapy in Japanese patients with head and neck cancer: a retrospective study.

Daichiro Fujiwara1,2, Masanobu Tsubaki2, Tomoya Takeda2, Makoto Miura3, Shozo Nishida2, Katsuhiko Sakaguchi4.   

Abstract

OBJECTIVES: The incidence of severe mucosal damage due to low nutritional status is high in patients receiving concurrent chemoradiotherapy (CCRT) for head and neck cancer. Objective assessments do not exist for discharge criteria after completion of CCRT. Although the prognostic nutritional index (PNI) is an objective indicator of postoperative outcomes in patients undergoing cancer surgery, the prognostic impact of the PNI in patients with head and neck cancer receiving CCRT is unexplored. We investigated whether the PNI could be an objective criterion for nutritional status and a discharge criterion after completion of CCRT.
METHODS: We assessed the medical records of 23 patients with head and neck cancer who received triweekly cisplatin +radiotherapy (2 Gy ×35 fractions). We evaluated whether the PNI could be a useful evaluation indicator in patients with head and neck cancer receiving CCRT and determined the cut-off PNI value by receiver operating characteristic (ROC) curve analysis as a criterion for hospital discharge.
RESULTS: The PNI pre-treatment and post-treatment values were 51.0 and 38.0, respectively (p<0.05). The median length of hospitalisation after therapy was 5 days in patients with grades 1 and 2 and 10 days in patients with grade 3 oral and pharyngeal mucositis (p<0.05). The optimal cut-off PNI value as a criterion for hospital discharge was found to be 40.4 (grades 1 and 2 mucositis) and 38.6 (grade 3 mucositis) by the ROC analysis.
CONCLUSIONS: The PNI is a simple, objective and temporal indicator which is useful in assessing the nutritional status of patients with head and neck cancer. The PNI could be used as an objective indicator to determine the time of discharge after CCRT completion. © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  concurrent chemoradiotherapy; head and neck cancer; mucositis; nutritional status; prognostic nutritional index

Mesh:

Year:  2019        PMID: 34426479      PMCID: PMC8403783          DOI: 10.1136/ejhpharm-2019-001979

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  17 in total

Review 1.  Proposal for classifying the acute emetogenicity of cancer chemotherapy.

Authors:  P J Hesketh; M G Kris; S M Grunberg; T Beck; J D Hainsworth; G Harker; M S Aapro; D Gandara; C M Lindley
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

2.  The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy.

Authors:  Jingjing Miao; Weiwei Xiao; Lin Wang; Fei Han; Haijun Wu; Xiaowu Deng; Xiang Guo; Chong Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-28       Impact factor: 4.553

3.  Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.

Authors:  Cem Mirili; Ali Yılmaz; Serkan Demirkan; Mehmet Bilici; Salim Basol Tekin
Journal:  Int J Clin Oncol       Date:  2019-05-09       Impact factor: 3.402

4.  [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients].

Authors:  T Onodera; N Goseki; G Kosaki
Journal:  Nihon Geka Gakkai Zasshi       Date:  1984-09

5.  Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer.

Authors:  J Bauer; S Capra; M Ferguson
Journal:  Eur J Clin Nutr       Date:  2002-08       Impact factor: 4.016

6.  Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.

Authors:  Susan A McCloskey; Wainwright Jaggernauth; Nestor R Rigual; Wesley L Hicks; Saurin R Popat; Maureen Sullivan; Terry L Mashtare; Mohamed K Khan; Thom R Loree; Anurag K Singh
Journal:  Am J Clin Oncol       Date:  2009-12       Impact factor: 2.339

7.  Poor radiotherapy compliance predicts persistent regional disease in advanced head/neck cancer.

Authors:  Urjeet A Patel; Monica O Patadia; Nathaniel Holloway; Fred Rosen
Journal:  Laryngoscope       Date:  2009-03       Impact factor: 3.325

Review 8.  Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer.

Authors:  Maddireddy Umameshwar Rao Naidu; Gogula Venkat Ramana; Pingali Usha Rani; Iyyapu Krishna Mohan; Avula Suman; Priyadarshni Roy
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

9.  Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Lin Yang; Liangping Xia; Yan Wang; Shaodong Hong; Haiyang Chen; Shaobo Liang; Peijian Peng; Yong Chen
Journal:  PLoS One       Date:  2016-07-11       Impact factor: 3.240

10.  Association of the prognostic nutritional index and overall survival in patients with colorectal cancer: A STROBE compliant retrospective cohort study.

Authors:  Julissa Luvián-Morales; Sagrario González-Trejo; José F Carrillo; Roberto Herrera-Goepfert; Vincenzo Aiello-Crocifoglio; Dolores Gallardo-Rincón; Francisco J Ochoa-Carrillo; Luis F Oñate-Ocaña
Journal:  Cancer Med       Date:  2019-05-08       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.